News for BioAtla, Inc. (BCAB)

Published at

Mar 28, 2025 8:04 AM

by gurufocus.com

neutral

neutral

BioAtla Inc (BCAB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

R&D Expenses: $11.6 million for Q4 2024, down from $22.7 million in Q4 2023.General and Administrative Expenses: $4.6 million for Q4 2024, down from $5.9 milli

MLWEL.PA MLKRI.PA BCAB

Read more →
Published at

Mar 28, 2025 6:04 AM

by gurufocus.com

positive

positive

Q4 2024 Bioatla Inc Earnings Call Transcript

Mar 27, 2025 / 08:30PM GMTOperator Good day, everyone, and welcome to today's BioAtla fourth quarter and fiscal year 2024 earnings call. (Operator Instructions)

BCAB

Read more →
Published at

Mar 27, 2025 11:18 PM

by seekingalpha.com

positive

positive

BioAtla, Inc. (BCAB) Q4 2024 Earnings Call Transcript

BioAtla, Inc. (NASDAQ:BCAB) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, Investor...

BCAB

Read more →
Published at

Mar 27, 2025 11:00 PM

by gurufocus.com

positive

positive

BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated 1H 2026 Mecbot

BCAB

Read more →
Published at

Mar 20, 2025 11:00 PM

by gurufocus.com

positive

positive

Context Therapeutics Reports Full Year 2024 Operating and Financial Results

CTIM-76 first patient dosed in January 2025 Cash and cash equivalents of $94.4 million as of December 31, 2024 Company expects its cash and cash equivalents w

BCAB

Read more →
Published at

Mar 20, 2025 9:44 PM

by manilatimes.net

positive

positive

Context Therapeutics Reports Full Year 2024 Operating and Financial Results

**media[572499]**

BCAB

Read more →
Published at

Mar 20, 2025 2:00 PM

by gurufocus.com

positive

positive

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings

SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. ( BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally

BCAB

Read more →
Published at

Mar 20, 2025 1:18 PM

by manilatimes.net

positive

positive

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings

**media[571855]**

BCAB

Read more →
Published at

Mar 19, 2025 2:00 PM

by gurufocus.com

positive

positive

BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025

SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. ( BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally

BCAB

Read more →
Published at

Jan 25, 2025 1:12 AM

by gurufocus.com

mixed

mixed

Millennium Management LLC Reduces Stake in BioAtla Inc.

On December 31, 2024, Millennium Management LLC executed a significant transaction involving BioAtla Inc. The firm reduced its holdings in the clinical-stage bi

SPOTD.BA NVDAD.BA NVDAC.BA NVDA.MI MSFTD.BA MSFTCL.SN MSFTC.BA MSFTB.BA MSFT.MI 0KZC.L BCAB

Read more →
Published at

Jan 2, 2025 6:00 PM

by zacks.com

neutral

neutral

BioAtla (BCAB) Upgraded to Buy: Here's What You Should Know

BioAtla (BCAB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BCAB

Read more →
Published at

Dec 20, 2024 3:26 PM

by manilatimes.net

positive

positive

BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points

**media[497855]**

BCAB

Read more →
Published at

Dec 20, 2024 3:04 PM

by investing.com

positive

positive

BioAtla announces $9.2 million stock and warrant sale By Investing.com

BioAtla announces $9.2 million stock and warrant sale

BCAB

Read more →
Published at

Nov 9, 2024 2:53 PM

by seekingalpha.com

positive

positive

BioAtla, Inc. (BCAB) Q3 2024 Earnings Call Transcript

BioAtla, Inc. (NASDAQ:BCAB) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 AM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, Investor...

BCAB

Read more →
Published at

Nov 8, 2024 10:03 PM

by gurufocus.com

neutral

neutral

BioAtla Inc (BCAB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

Research and Development Expenses: $16.4 million for Q3 2024, down from $28.4 million in Q3 2023.General and Administrative Expenses: $5.9 million for Q3 2024,

BCAB

Read more →
Published at

Nov 8, 2024 9:19 PM

by gurufocus.com

positive

positive

Q3 2024 Bioatla Inc Earnings Call Transcript

Nov 07, 2024 / 09:30PM GMTOperator Good day, everyone and welcome to today's Bioatla third-quarter, 2024 earnings call. (Operator Instructions) It is now my ple

BCAB

Read more →
Published at

Oct 20, 2024 10:06 PM

by insidermonkey.com

mixed

mixed

BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading Into 2025

We recently compiled a list of the Michael Burry's Top 10 Stock Picks Heading into 2025. In this article, we are going to take a look at where BioAtla, Inc.

MSCL.SN BCAB TGTCL.SN TGT.SN

Read more →
Published at

Oct 17, 2024 9:57 AM

by insidermonkey.com

mixed

mixed

Michael Burry’s Top 10 Stock Picks Heading into 2025

Established in May 2013, Scion Asset Management is a renowned and well-regarded California-based hedge fund founded by Michael Burry.

BCAB TGTCL.SN TGT.SN

Read more →
Published at

Oct 14, 2024 11:16 AM

by acquirersmultiple.com

positive

positive

Michael Burry – Top 10 Holdings – Latest 13F

One of the best resources for investors are the publicly available 13F-HR documents that each fund is required to submit to the SEC. These documents allow inves...

REAL MOH JDN.MX JDCO34.SA JDCMF JD.BA JD HPP FOUR BIDUN.MX BIDUD.BA BIDU.BA BIDU BCAB BAIDF 9888.HK 9618.HK

Read more →
Published at

Oct 4, 2024 2:35 PM

by rttnews.com

mixed

mixed

Pre-market Movers: BENF, SAVE, CETX, PW, AVGR…

Texas-based Beneficient (BENF), a technology-enabled financial services company is up over 55 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

ZIM WORX SILV SIL.TO PW OCFT LIFE BCAB APOG ACMR 0VHI.L SOBR SAVE RDW CETXP CETX AVGR 0L8U.L SND BDSX

Read more →